Haloperidol vs. placebo for the treatment of delirium in ICU patients: a pre-planned, secondary Bayesian analysis of the AID-ICU trial.

Nina Christine Andersen-RanbergLone Musaeus PoulsenAnders PernerJohanna HästbackaMatthew MorganGiuseppe CiterioMarie Oxenbøll ColletSven-Olaf WeberAnne Sofie AndreasenMorten BestleBülent UsluHelle Scharling PedersenLouise Gramstrup NielsenKjeld DamgaardTroels Bek JensenTrine SommerNilanjan DeyOle MathiesenAnders Granholm

Published in: Intensive care medicine (2023)

We found high probabilities of benefits and low probabilities of harm with haloperidol treatment compared with placebo in acutely admitted, adult ICU patients with delirium for the primary and most secondary outcomes.

Keyphrases

intensive care unit
end stage renal disease
phase iii
clinical trial
chronic kidney disease
newly diagnosed
cardiac surgery
mechanical ventilation
type diabetes
study protocol
double blind
ejection fraction
adipose tissue
weight loss
phase ii
replacement therapy